Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, today announced it has appointed Dr Nicola Thompson as Chair of its Board of Directors.
Lung cancer prediction using biomarkers based on bronchoalveolar fluid microbiomes
The lung microbiomes of patients with benign and malignant pulmonary diseases.